Outpatient coronary angioplasty, is it possible?

Original title: Assessment of Clinical Outcomes related to Early Discharge alter elective Percutaneous Coronary Intervention: COED PCI Reference: Purushothaman Muthusamy MD, et al. Catheterization and Cardiovascular Intervention 81:6-13 (2013)

The standard procedure in most institutions is that after angioplasty (PTCA) patients are discharged the next morning. There are some reports in which they were ambulatory but the safety of this has not been well established. 

The aim of this study was to analyze the results of patients who underwent PTCA and were granted discharge on the same day. We analyzed 200 consecutive patients admitted for PTCA scheduled from December 2008 to June 2011 in only one hospital. Follow-up was conducted by telephone within 24 hours and after 7 days by trained nurses.

We evaluated vascular complications, readmissions, symptoms and MACE (combination of death, myocardial infarction, urgent revascularization and pulmonary embolism). All patients received pretreatment with aspirin and clopidogrel or prasugrel. The access was femoral in 75.5% of patients with 60% utilization of a percutaneous closure device. The access was radial for the remaining 24.5%. 

Patients with femoral access stay at rest for 2-3 hours if CPB was used and 4-6 hours if it was manual compression. Ambulation time after the procedure was 4.5 ± 1.9 hours for the femoral access and 3.9 ± 1.3 hours for radial access. There was no major bleeding or MACE at 24 hours or 7 days. Minor bleeding was present in 8 patients (4%), 6 of them had femoral access. Readmission within 24 hours was 1.5%, (one patient for non-cardiac chest pain and edema in the access site). 

Within 7 days another 3 patients were readmitted (1.5%), one has pericarditis, one for non-cardiac chest pain and one having psuedoaneurisma that was resolved using a thrombin injection.

Conclusion 

Identifying angioplasty low risk patients, performing the procedure and subsequent discharge on the same day was safe with a low rate of short-term complications.

Editorial Comment:

Although this is a non-randomized study and not controlled, results are encouraging and allow lower costs and increased hospital bed availability. Hospitalization costs can be further reduced by increasing the percentage of radial access and thereby saving on percutaneous closure devices. More research is needed in this area in order to make this behavior used more often. 

Thanks to Dr Carlos Fava.
Interventional Cardiologist.
Favaloro Foundation. Argentina.

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...